Latest News...

> PharmE3D Labs Earn Multiple Pharmaceutical Science Distinctions

> 3D Printing In Personalized Drug Delivery

> CoM3D and University of Texas at Austin sign patent license agreement

> CoM3D Secures up to £1M in New Funding

> CoM3D developing hybrid anti-viral delivery systems

> Maniruzzaman Lab collaboration works to develop patient-focused medicines more efficiently

> CoM3D appoints Alastair Syvret to Advisory Panel

> CoM3D appoints Dr Anthony Thomson as CEO.